Xiangxue Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xiangxue Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Guizhou Bailing Group Pharmaceutical Company Limited
sales of 2.85 billion Chinese Renmimbi [US$417.72 million]
of which 84%
Mayinglong Pharmaceutical Group Co Ltd
(2.70 billion Chinese Renmimbi [US$396.33 million]
of which 54%
was Pharmaceutical Industry), and
Sihuan Pharmaceutical Holdings Group Ltd
(2.89 billion Chinese Renmimbi [US$423.06 million]
of which 100%
was Manufaturing and Sale of Pharmaceutical ).
During the year ended December of 2019, sales at
Xiangxue Pharmaceutical Co Ltd were 2.79 billion Chinese Renmimbi (US$408.29 million).
increase of 11.3%
versus 2018, when the company's sales were 2.50 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Xiangxue Pharmaceutical Co Ltd.
Sales of Chinese Herbal Medicines saw an increase
that was more than double the company's growth rate: sales were up
46.3% in 2019, from
924.85 million Chinese Renmimbi to 1.35 billion Chinese Renmimbi.
Xiangxue Pharmaceutical Co Ltd also saw significant increases in sales in
Pharmaceutical Manufacturing (up 32.9% to 767.81 million Chinese Renmimbi)
Not all segments of Xiangxue Pharmaceutical Co Ltd experienced an increase in sales in 2019:
sales of Medical Apparatus and Instruments fell 6.0% to 15.83 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).